Acikgoz Y, Ergun Y, Ucar G, Dirikoc M, Uncu D. The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients: Her2-positive metastatic breast cancer patients. Acta Medica. 2019;50(4):14-19. https://doi.org/10.32552/2019.ActaMedica.395